Safeway Lifesciences Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 16-12-2024
- Paid Up Capital ₹ 0.50 M
as on 16-12-2024
- Company Age 18 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 9.00 M
as on 16-12-2024
- Revenue 10.71%
(FY 2021)
- Profit -25.50%
(FY 2021)
- Ebitda 2.58%
(FY 2021)
- Net Worth 1.37%
(FY 2021)
- Total Assets 85.58%
(FY 2021)
About Safeway Lifesciences
The Corporate was formerly known as Safeway Lifesciences. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹9.00 M.
Rashid Rangwala and Hussain Rangwala serve as directors at the Company.
- CIN/LLPIN
U24232GJ2006PTC048572
- Company No.
048572
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
28 Jun 2006
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Ahmedabad, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Safeway Lifesciences?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Hussain Rangwala  | Director | 13-Apr-2024 | Current |
| Rashid Rangwala | Additional Director | 13-Apr-2024 | Current |
Financial Performance of Safeway Lifesciences.
Safeway Lifesciences Private Limited, for the financial year ended 2021, experienced significant growth in revenue, with a 10.71% increase. The company also saw a substantial fall in profitability, with a 25.5% decrease in profit. The company's net worth moved up by a moderate rise of 1.37%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Safeway Lifesciences?
In 2021, Safeway Lifesciences had a promoter holding of 97.00% and a public holding of 3.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Unisafe Bioscience Private LimitedActive 31 years 8 monthsRashid Rangwala and Hussain Rangwala are mutual person
- Gujarat Medicraft Private LimitedActive 34 years 5 months
Rashid Rangwala and Hussain Rangwala are mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
Indian Bank Creation Date: 22 May 2024 | ₹9.00 M | Open |
How Many Employees Work at Safeway Lifesciences?
Unlock and access historical data on people associated with Safeway Lifesciences, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Safeway Lifesciences, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Safeway Lifesciences's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
